Status:
WITHDRAWN
Subscapularis Repair During Reverse Total Shoulder Arthroplasty
Lead Sponsor:
Northwestern University
Conditions:
Shoulder Osteoarthritis
Arthropathy Shoulder
Eligibility:
All Genders
18-88 years
Phase:
NA
Brief Summary
This multi-site study involving Northwestern Medicine, Beaumont Health, and Loyola Medicine seeks to answer the following question: do patients who undergo subscapularis (SSc) repair during reverse to...
Eligibility Criteria
Inclusion
- Primary RSA procedure with repairable (intact) SSc
- Operation will be performed by a participating surgeon using Zimmer Biomet Comprehensive Reverse Shoulder System implant
- Diagnosis with imaging of arthropathy with rotator cuff insufficiency
- Surgical approach: Deltopectoral
- Fluent English speakers/readers
Exclusion
- Minor (\<18 y/o)/vulnerable populations (pregnant women, prisoners, adults unable to consent)
- Revision surgery
- Oncologic surgery
- non-ZB CRSS implants
- Unrepairable SSc
Key Trial Info
Start Date :
January 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05341518
Start Date
January 2 2023
End Date
August 1 2025
Last Update
March 15 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Loyola Medicine
Maywood, Illinois, United States, 60153
2
Beaumont Health
Royal Oak, Michigan, United States, 48073